Solstice Neurosciences

company

About

Solstice Neurosciences is focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products.

  • 51 - 100

Details

Industries
Biotechnology,Manufacturing,Marketing
Founded date
Jan 1, 2003
Number Of Employee
51 - 100
Operating Status
Active

Solstice Neurosciences is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solstice's first product named Myobloc® (rimabotulinumtoxinB) Injection in the U.S. and NeuroBloc® (Botulinum Toxin Type B) Injectable Solution in select overseas markets, represents the only botulinum toxin type B currently available to physicians and patients worldwide.